Immunological factors and their role in the genesis and development of endometriosis ARTICLE HAS BEEN RETRACTED

The article presents an overview of immunological factors and their role in the genesis and development of endometriosis, with emphasis on inflammatory cytokines and growth and adhesion factors. Although retrograde menstruation is a common phenomenon among women of reproductive age, not all women wi...

Full description

Saved in:
Bibliographic Details
Published inThe journal of obstetrics and gynaecology research Vol. 32; no. 2; pp. 162 - 170
Main Authors Siristatidis, Charalambos, Nissotakis, Christos, Chrelias, Charalambos, Iacovidou, Helen, Salamalekis, Emmanuel
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.04.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The article presents an overview of immunological factors and their role in the genesis and development of endometriosis, with emphasis on inflammatory cytokines and growth and adhesion factors. Although retrograde menstruation is a common phenomenon among women of reproductive age, not all women with retrograde menstruation suffer the disease. Development of endometriosis seems to be a complex process, facilitated by several factors, including quantity and quality of endometrial cells in peritoneal fluid (PF), increased inflammatory activity in PF, increased endometrial–peritoneal adhesion and angiogenesis, reduced immune surveillance and clearance of endometrial cells, and increased production of autoantibodies against endometrial cells. Potential biomarkers like cytokines and autoantibodies, upregulated during development of endometriosis, seem useful in the development of a non‐surgical diagnostic tool. In this review work, the immune role in endometriosis is examined through the role of immunological factors in the genesis and development of the disease. Furthermore, it could be concluded that, although endometriosis can be treated using hormonal suppression, there is a need today for non‐hormonal drugs, probably to modulate immune function, in order to confront the disease and alleviate pain or infertility without inhibition of ovulation.
Bibliography:istex:0A551B0DB0E29EE890EDEF61F30198D255214D1E
ark:/67375/WNG-G3PHDC5B-L
ArticleID:JOG373
ISSN:1341-8076
1447-0756
DOI:10.1111/j.1447-0756.2006.00373.x